Our mission is to improve the quality of human life by enabling people to do more, feel better, live longer. Discover more about us below...
We are researching the World Health Organization's three priority diseases - HIV/AIDS, tuberculosis and malaria.
£4 billion invested in 2012 in our search to develop new medicines, vaccines and consumer products.
Between 2008 and 2012, we have had 23 new medicines approved in the USA and Europe.
Late-stage assets in our product pipeline (to the end of 2012)
Manufacturing sites in 34 countries make our medicines, vaccines and consumer healthcare products.
The year GSK was created through the merger of GlaxoWellcome and SmithKline Beecham.
In 2009 we launched ViiV Healthcare with Pfizer to deliver advances in treatment and care for people living in HIV.
Our vision is for our value chain to be carbon neutral by 2050.
More than 12,500 people work in R&D in our search for new medicines, vaccines and consumer healthcare products.
We employ more than 99,000 people in over 100 countries, with more than a third of these in emerging markets.
Number of vaccine doses we supplied across 170 countries in 2012, 80% of which were to developing countries.
We manufacture and distribute more than 4 billion packs of products to over 150 countries around the world every year.